Gene expression and mutation profiling for cancer of unknown primary

被引:0
|
作者
Hayashi, Hidetoshi [1 ]
Tomida, Shuta [2 ,3 ]
Fujita, Yoshihiko [2 ]
Togashi, Yosuke [2 ,4 ]
Sakai, Kazuko [2 ]
Nishio, Kazuto [2 ]
Nakagawa, Kazuhiko [1 ]
机构
[1] Kindai Univ, Dept Med Oncol, Higashiosaka, Osaka, Japan
[2] Kindai Univ, Dept Genome Biol, Higashiosaka, Osaka, Japan
[3] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biobank, Okayama, Japan
[4] Natl Canc Ctr, Div Canc Immunol, Exploratory Oncol Res & Clin Trial Ctr, Tokyo, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ISY13-4
引用
收藏
页数:1
相关论文
共 50 条
  • [31] The role of molecular profiling in the diagnosis and management of metastatic undifferentiated cancer of unknown primary* Molecular profiling of metastatic cancer of unknown primary
    Dermawan, Josephine K.
    Rubin, Brian P.
    SEMINARS IN DIAGNOSTIC PATHOLOGY, 2021, 38 (06) : 193 - 198
  • [32] Clinicopathological characteristics of cancer of unknown primary (CUP) with renal profile using gene expression profiling (GEP) based cancer classification.
    Allam, Joelle
    Ma, Li
    Zhao, Jianping
    Estrella, Jeannelyn
    Higbie, Victoria
    Willett, Anneleis
    Matamoros, Aurelio
    Lano, Elizabeth A.
    Treuner, Kai
    Raghav, Kanwal Pratap Singh
    Huey, Ryan W.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [33] Development and validation of a gene expression tumour classifier for cancer of unknown primary
    Tothill, Richard W.
    Shi, Fan
    Paiman, Lisa
    Bedo, Justin
    Kowalczyk, Adam
    Mileshkin, Linda
    Buela, Evangeline
    Klupacs, Robert
    Bowtell, David
    Byron, Keith
    PATHOLOGY, 2015, 47 (01) : 7 - 12
  • [34] Gene expression profiling (GEP) to predict the primary site of metastatic neuroendocrine tumors (NETs) presenting with an unknown primary
    Woltering, Eugene
    Anthony, Lowell Brian
    Diebold, Anne E.
    Boudreaux, J. Philip
    Wang, Yi-Zarn
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [35] Classification of cancers of unknown primary from parrafin embedded tissues using gene expression profiling
    Floore, A
    Ma, XJ
    Warmoes, M
    Glas, AM
    Erlander, M
    ANNALS OF ONCOLOGY, 2005, 16 : 314 - 315
  • [36] Defining a Distinct Immunotherapy Eligible Subset of Patients with Cancer of Unknown Primary Using Gene Expression Profiling with the92-GeneAssay
    Raghav, Kanwal
    Overman, Michael
    Poage, Graham M.
    Soifer, Harris S.
    Schnabel, Catherine A.
    Varadhachary, Gauri R.
    ONCOLOGIST, 2020, 25 (11): : E1807 - E1811
  • [37] Gene expression profiling for oncogenic Kras mutation in mice and human colorectal cancer
    Niitsu, Hiroaki
    Hinoi, Takao
    Kawaguchi, Yasuo
    Sentani, Kazuhiro
    Oue, Naohide
    Sotomaru, Yusuke
    Adachi, Tomohiro
    Saito, Yasufumi
    Miguchi, Masashi
    Kochi, Masatoshi
    Shimomura, Manabu
    Yasui, Wataru
    Ohdan, Hideki
    CANCER RESEARCH, 2015, 75
  • [38] Gene expression profiling to predict chemotherapy response in primary breast cancer
    Schneeweiss, Andreas
    Lichter, Peter
    Sohn, Christof
    Hahn, Meinhard
    BREAST CARE, 2006, 1 (06) : 362 - 367
  • [39] Quantitative multi-gene expression profiling of primary prostate cancer
    Unversucht, S.
    Schmidt, U.
    Meye, A.
    Fuessel, S.
    Koch, R.
    Baretton, G. B.
    Froehner, M.
    Wirth, M. P.
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (14) : 789 - 789
  • [40] Quantitative multi-gene expression profiling of primary prostate cancer
    Schmidt, Uta
    Fuessel, Susanne
    Koch, Rainer
    Baretton, Gustavo B.
    Lohse, Andrea
    Tomasetti, Silke
    Unversucht, Susanne
    Froehner, Michael
    Wirth, Manfred P.
    Meye, Axel
    PROSTATE, 2006, 66 (14): : 1521 - 1534